| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Jonathan C Fox is Director at EWTX. Jonathan C Fox's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $947K at current prices.
Net of sales, the EWTX filings show accumulation of 21,557 shares.
Jonathan C Fox has 14 Form 4 filings on record from March 2023 to October 2026, all as Director at Edgewise Therapeutics (EWTX), 2023–2026.
The 14 reported transactions were 7 stock awards, 5 option or other derivative awards and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $300K and no sales.
The largest open-market purchase was 10,700 shares of EWTX at an average $18.64 on November 11, 2025, about $199K.